statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

XOMA Corporation Announces Closing of Tender Offer

Kinnate Stockholders to Receive $2.5879 Per Share in Cash Plus Contingent Value RightEMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) ( XOMA or the Company...

INVESTIGATION ALERT: Halper Sadeh LLC Investigates LABP, FUSN, KNTE

INVESTIGATION ALERT: Halper Sadeh LLC Investigates LABP, FUSN, KNTE INVESTIGATION ALERT: Halper Sadeh LLC Investigates LABP, FUSN, KNTE PR Newswire NEW YORK, March 25, 2024 NEW YORK, March 25, 2024...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, SCTL, KNTE

NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.

Upon closing, XOMA anticipates adding approximately $9.5 million in cash to its balance sheet and several early-stage programs to potentially add to its royalty portfolioEMERYVILLE, Calif., March...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, HRT, NGM, KNTE

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, HRT, NGM, KNTE SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, HRT, NGM, KNTE PR Newswire NEW YORK, March 18, 2024 NEW YORK, March 18...

INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger   TGAN, HMST, KNTE

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the M&A Class Action Firm ), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FANG, FREE, KNTE

NEW YORK, March 16, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates KNTE, DOOR, HMST

NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger   KNTE, DOOR, HMST

NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the M&A Class Action Firm ), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DOOR, FREE, KNTE

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DOOR, FREE, KNTE SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DOOR, FREE, KNTE PR Newswire NEW YORK, March 12, 2024 NEW YORK, March 12, 2024...

Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers. Its mission is to expand the reach of targeted therapeutics by developing products for underserved populations.  The company utilizes its deep expertise in structure-based drug discovery, translational research, and patient-driven precision medicine. Its programs include candidates in preclinical development for cancers that are driven by specific oncogenic alterations in either the BRAF kinase gene or in the FGFR2 and FGFR3 kinase genes.

Volume	2.81M
52-Wk High	$6.00
52-Wk Low	$1.04

KNTE Kinnate Biopharma Inc

About

Feed

News

Earnings

Fundamentals